Improving diagnosis of von Willebrand disease: Reference ranges for von Willebrand factor multimer distribution

BACKGROUND: Phenotypic von Willebrand disease (VWD) classification requires multiple tests including analysis of multimeric distributions von Willebrand factor (VWF) and evaluation of its structure. VWF multimer analysis is labor intensive, nonstandardized, and limited to specialized laboratories. A commercial semiautomatic assay, HYDRAGEL VW multimer assay (H5/11VWM, Sebia), has become available. OBJECTIVES: Establishment of reference ranges for H5/11VWM to improve VWD classification. METHODS: Implementation validation, establishment and validation of normal and pathological reference intervals (NRIs/PRIs), comparison with in‐house method using 40 healthy volunteers and 231 VWD patients. RESULTS: Qualitative and quantitative validation of NRI obtained sensitivity of 88% and 79%, respectively, for type 2. Comparison of the two methods showed an overall concordance of 86% with major conflicting results in all atypical 2B (n = 7) and 50% 2M‐GPIb (n = 41) showing quantitative and qualitative multimeric loss, that was not detected with in‐house method. We were able to use established PRIs, with 73% validity in type 2 cases, to distinguish individual type 2A subtypes (IIA, IIC, IID, IIE) from 2M and 2B. CONCLUSION: H5/11VWM could be used for all clinical purposes because its reliability and its rapid and accurate diagnostic ability and reduced observer bias. Although H5/11VWM cannot evaluate triplet structures, we were able to define 2A subtypes by stripping back to the percentage of intermediate/high‐molecular‐weight multimers. H5/11HWM could be an efficient and widely available alternative for the “gold standard” technique.